34 Results for "

brain exposures

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "brain exposures" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0459
CAS No.: 498-45-3
Synonyms: 6,7-Epoxytropine
Scopine is a metabolite of Scopolamine (HY-N0296) and brain-targeting compound. Scopine significantly increases the brain exposure of Chlorambucil (HY-13593) and enhances its anti-glioma activity. Scopine can be used in targeted therapy research for brain gliomas .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0459A
CAS No.: 85700-55-6
Synonyms: 6,7-Epoxytropine hydrochloride
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease Cancer

Scopine hydrochloride is a metabolite of Scopolamine (HY-N0296) and brain-targeting compound. Scopine hydrochloride significantly increases the brain exposure of Chlorambucil (HY-13593) and enhances its anti-glioma activity. Scopine hydrochloride can be used in targeted therapy research for brain gliomas .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116565
CAS No.: 1428862-33-2
Purity:  ≥98.0%
Synonyms: SUVN-D4010
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Usmarapride (SUVN-D4010) (Example 3)is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=27.5 nM). Usmarapride (SUVN-D4010) can be used for the research of cognitive deficits associated with Alzheimer's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116565A
CAS No.: 1428862-32-1
Purity:  99.91%
Synonyms: SUVN-D4010 free base
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Usmarapride (SUVN-D4010) free base is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM). Usmarapride (SUVN-D4010) free base can be used for the research of cognitive deficits associated with Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-W017424
CAS No.: 136-95-8
2-Aminobenzothiazole acts as a caspase 3/7 activator, an anticancer cytotoxic agent, and also exhibits neurotoxicity. 2-Aminobenzothiazole drives the apoptotic pathway by activating caspase 3/7, induces mitochondrial inner membrane depolarization, and triggers both early and late apoptosis via a caspase-dependent pathway. In zebrafish models, 2-Aminobenzothiazole induces oxidative damage in brain tissues and inhibits genes related to GABA and 5-HT synthesis pathways. Long-term exposure to 2-Aminobenzothiazole impairs motor ability, social behavior, anxiety-like state and cognitive function. 2-Aminobenzothiazole can be used in studies of human laryngeal carcinoma and related neurotoxicity .
loading...
    loading...
Cat. No.: HY-148233S
CAS No.: 2765264-50-2
JNJ-6204 is a dual inhibitor for CSNK1D (Casein Kinase 1 Delta) and CSNK1E (Casein Kinase 1 Epsilon) (CSNK1D IC50=2.3 nM; CSNK1E IC50=137 nM). JNJ-6204 shows good brain exposure .
loading...
    loading...
Cat. No.: HY-163087
CAS No.: 3037561-48-8
Target:  

Orphan GPCR

PT-91 is an agonist of GPR27. PT-91 exhibits high metabolic stability and brain exposure in mice .
loading...
    loading...
Cat. No.: HY-110146
CAS No.: 196928-50-4
Purity:  99.99%
Target:  

mGluR

Research Areas:  

Neurological Disease

XAP044 is a potent and selective antagonist of mGlu7. The metabotropic glutamate receptor subtype 7 (mGlu7) is an important presynaptic regulator of neurotransmission in the mammalian CNS. XAP044 demonstrates good brain exposure and wide spectrum anti-stress and antidepressant- and anxiolytic-like efficacy in rodent behavioral paradigms .
loading...
    loading...
Cat. No.: HY-124713
CAS No.: 1331745-61-9
Purity:  99.43%
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease

ML372 inhibits survival motor neuron (SMN) protein ubiquitination, increases SMN protein stability without affecting mRNA expression. ML372 improves spinal muscular atrophy (SMA) in mice. ML372 is brain penetrant and has a reasonable exposure and half-life in vivo .
loading...
    loading...
Cat. No.: HY-155672
CAS No.: 5972-45-2
Purity:  99.5%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

JPC0323 is a dual 5-HT2C/5-HT2A receptor positive allosteric modulator. JPC0323 has on-target properties, acceptable plasma exposure and brain penetration. JPC0323 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-120496
CAS No.: 1204178-50-6
Synonyms: ASP3662
Target:  

11β-HSD

Clofutriben (ASP3662) is a selective, orally active and brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with Ki values of 5.3 nM (human), 2.6 nM (mouse), and 23 nM (rat). Clofutriben inhibits conversion of inactive glucocorticoids to active glucocorticoids, reducing intracellular glucocorticoid exposure. Clofutriben ameliorates neuropathic pain, and restores muscle pressure thresholds in rodent models, while lacking effects in inflammatory pain .
loading...
    loading...
Cat. No.: HY-130609A
CAS No.: 2434633-17-5
Target:  

γ-secretase

Research Areas:  

Neurological Disease

Aβ42-IN-1 free base (compound 1v) is an orally active, high brain exposure γ-secretase modulator. Aβ42-IN-1 free base potently reduces Aβ42 levels with an IC50 value of 0.091 μM, and significantly reduces brain Aβ42 levels in mice. Aβ42-IN-1 free base is a promising compound for the treatment of Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-130609
CAS No.: 2582757-69-3
Target:  

γ-secretase

Research Areas:  

Neurological Disease

Aβ42-IN-1, compound 1v, is a novel, potent and orally active?γ-secretase modulator (GSM). Aβ42-IN-1 potently reduced Aβ42 levels with an IC50?value of 0.091?μM without CYP3A4 inhibition. Aβ42-IN-1 shows a sustained pharmacokinetic profile.
loading...
    loading...
Cat. No.: HY-147720
CAS No.: 2434630-29-0
Target:  

γ-secretase

Research Areas:  

Neurological Disease

γ-Secretase modulator 11 (1o) showed high potency in vitro and brain exposure, inducing brain a β 42 levels were significantly reduced and showed undetectable inhibition of cytochrome P450 enzymes. In addition, compound 1o showed excellent anti cognitive deficit effect in AD model mice.
loading...
    loading...
Cat. No.: HY-147684
CAS No.: 2488764-17-4
Target:  

FGFR

Research Areas:  

Neurological Disease

FGFR-IN-7 (compound 17) is an orally active, potent and BBB-penetrated FGFR (fibroblast growth factor receptor) modulator. FGFR-IN-7 shows neuroprotective activity. FGFR-IN-7 improves brain exposure and reduced risk of phospholidosis. FGFR-IN-7 can be used for neurodegenerative diseases research .
loading...
    loading...
Cat. No.: HY-158627
CAS No.: 1612785-68-8
Target:  

5-HT Receptor

Research Areas:  

Others

JPC0323 Oleate is a derivative of JPC0323 (HY-155672). JPC0323 is a dual 5-HT2C/5-HT2A receptor positive allosteric modulator. JPC0323 has on-target properties, acceptable plasma exposure and brain penetration. JPC0323 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-169310
CAS No.: 2878473-51-7
Target:  

ATM/ATR

Research Areas:  

Cancer

ATM Inhibitor-11 (Compound 1) is an inhibitor for ATM with an IC50 of 0.32 nM. ATM Inhibitor-11 inhibits the KAP1 phosphorylation with an IC50 of 0.97 nM. ATM Inhibitor-11 exhibits high exposure in the brain, heart and plasma of ICR mouse. ATM Inhibitor-11 exhibits anti-tumor efficacy in NCI-H441 xenograft mouse model .
loading...
    loading...
Cat. No.: HY-155992
CAS No.: 2849471-75-4
Purity:  98.70%
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

WLB-89462 (Compound 20c) is a selective σ2 receptor ligand (Ki: 13 nM). WLB-89462 has neuroprotective activity. WLB-89462 improves short-term memory impairment induced by Aβ peptide in rats. WLB-89462 has good ADMET profile (good solubility, no CYP inhibition, good metabolic stability, high permeability, brain penetration, and high oral exposure in rodents) .
loading...
    loading...
Cat. No.: HY-104044A
CAS No.: 2086689-94-1
Synonyms: BGB-290 maleate
Target:  

Apoptosis

Research Areas:  

Neurological Disease

Pamiparib maleate (BGB-290 maleate) is a highly potent and selective PARP inhibitor with neurotoxicity-inducing activity. Pamiparib maleate can effectively penetrate the blood-brain barrier and cause cerebral hemorrhage, brain atrophy, and movement disorders in zebrafish embryos exposed. Pamiparib maleate exposure downregulates the activities of acetylcholinesterase (AChE) and adenosine triphosphatase (ATPase) and leads to upregulation of oxidative stress, which triggers apoptosis and interferes with the expression of neurodevelopment-related genes. The use of pamiparib maleate is also accompanied by downregulation of the Notch signaling pathway, while activation of the Notch signaling pathway can partially rescue neurodevelopmental toxicity. Therefore, pamiparib maleate provides a reference for evaluating its potential neurotoxicity during embryonic development .
loading...
    loading...
Cat. No.: HY-120144
CAS No.: 1594121-16-0
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

SR-8993 is a highly selective nociceptin receptor agonist that can penetrate the blood-brain barrier and has the activity of reducing alcohol intake and relieving withdrawal anxiety. SR-8993 has shown mild anxiolytic effects in animal models and can effectively reverse anxiety caused by acute alcohol withdrawal. SR-8993 further reduces restricted drinking, operant responses for alcohol, and increased drinking induced by long-term intermittent exposure to alcohol. SR-8993 also reduces stress- and cue-related alcohol-seeking relapse .
loading...
    loading...